Table 3 Prospective association analysis between source-specific noise annoyance and incident CVD at 5-year follow-up.

From: Noise annoyance and cardiovascular disease risk: results from a 10-year follow-up study

Noise annoyance

N

Model 3

OR per point increase [95% CI]

P value

During day

 Road traffic

8589

0.93 [0.82; 1.03]

0.14

 Aircraft

8585

0.98 [0.90; 1.07]

0.68

 Railway

8581

0.91 [0.75; 1.08]

0.30

 Industrial

8579

0.97 [0.81; 1.14]

0.74

 Neighborhood

8585

1.02 [0.90; 1.15]

0.80

During Sleep

 Road traffic

8573

0.84 [0.69; 1.00]

0.064

 Aircraft

8573

0.92 [0.83; 1.02]

0.11

 Railway

8570

1.03 [0.83; 1.25]

0.76

 Industrial

8568

0.34 [0.09; 0.74]

0.034

 Neighborhood

8573

0.95 [0.80; 1.11]

0.52

Overall

 Road traffic

8589

0.91 [0.81; 1.01]

0.080

 Aircraft

8587

0.98 [0.90; 1.06]

0.62

 Railway

8583

0.94 [0.79; 1.10]

0.45

 Industrial

8584

0.95 [0.79; 1.11]

0.53

 Neighborhood

8585

1.02 [0.91; 1.14]

0.73

  1. Odds ratios (OR) and 95% confidence intervals (CI) are derived from a logistic regression model modeling for incident cardiovascular disease (CVD, composite variable comprising atrial fibrillation, coronary artery disease, myocardial infarction, stroke, chronic heart failure, peripheral artery disease, and venous thromboembolism per point increase in noise annoyance).
  2. N denotes model 3.
  3. Model 3 was adjusted for sex, age, socioeconomic status, night shift work, use of earplugs, years lived in residence, diabetes mellitus, arterial hypertension, smoking, obesity, dyslipidemia, family history of myocardial infarction or stroke, and medication use (diabetic drugs, antithrombotic agents, antihypertensives, diuretics, beta-blockers, calcium channel blocker, agents acting on the renin–angiotensin–aldosterone system, and lipid modifying agents).
  4. Significant values are in [bold].
Back to article page